PETIQ INC (PETQ)

US71639T1060 - Common Stock

30.98  -0.01 (-0.03%)

After market: 30.98 0 (0%)

Fundamental Rating

5

Taking everything into account, PETQ scores 5 out of 10 in our fundamental rating. PETQ was compared to 108 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of PETQ get a neutral evaluation. Nothing too spectacular is happening here. PETQ has a correct valuation and a medium growth rate.



6

1. Profitability

1.1 Basic Checks

In the past year PETQ was profitable.
In the past year PETQ had a positive cash flow from operations.
In the past 5 years PETQ reported 4 times negative net income.
PETQ had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

The Return On Assets of PETQ (1.48%) is better than 61.74% of its industry peers.
With a decent Return On Equity value of 5.13%, PETQ is doing good in the industry, outperforming 67.83% of the companies in the same industry.
PETQ has a better Return On Invested Capital (7.96%) than 80.87% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PETQ is below the industry average of 8.15%.
The last Return On Invested Capital (7.96%) for PETQ is above the 3 year average (4.51%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.48%
ROE 5.13%
ROIC 7.96%
ROA(3y)-2.53%
ROA(5y)-4%
ROE(3y)-9.44%
ROE(5y)-13.98%
ROIC(3y)4.51%
ROIC(5y)N/A

1.3 Margins

PETQ has a better Profit Margin (1.17%) than 64.35% of its industry peers.
PETQ has a better Operating Margin (6.32%) than 70.43% of its industry peers.
In the last couple of years the Operating Margin of PETQ has grown nicely.
The Gross Margin of PETQ (24.63%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of PETQ has grown nicely.
Industry RankSector Rank
OM 6.32%
PM (TTM) 1.17%
GM 24.63%
OM growth 3YN/A
OM growth 5Y28.63%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.79%
GM growth 5Y7.79%

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PETQ is still creating some value.
Compared to 1 year ago, PETQ has more shares outstanding
PETQ has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PETQ has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.60 indicates that PETQ is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.60, PETQ is doing good in the industry, outperforming 66.09% of the companies in the same industry.
PETQ has a debt to FCF ratio of 36.99. This is a negative value and a sign of low solvency as PETQ would need 36.99 years to pay back of all of its debts.
PETQ's Debt to FCF ratio of 36.99 is in line compared to the rest of the industry. PETQ outperforms 54.78% of its industry peers.
A Debt/Equity ratio of 1.69 is on the high side and indicates that PETQ has dependencies on debt financing.
With a Debt to Equity ratio value of 1.69, PETQ is not doing good in the industry: 73.04% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.69
Debt/FCF 36.99
Altman-Z 2.6
ROIC/WACC1.05
WACC7.57%

2.3 Liquidity

A Current Ratio of 2.58 indicates that PETQ has no problem at all paying its short term obligations.
PETQ has a Current ratio of 2.58. This is amongst the best in the industry. PETQ outperforms 82.61% of its industry peers.
A Quick Ratio of 1.68 indicates that PETQ should not have too much problems paying its short term obligations.
PETQ has a better Quick ratio (1.68) than 66.09% of its industry peers.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 1.68

6

3. Growth

3.1 Past

PETQ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.58%, which is quite impressive.
PETQ shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.07% yearly.
Looking at the last year, PETQ shows a quite strong growth in Revenue. The Revenue has grown by 13.57% in the last year.
PETQ shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.83% yearly.
EPS 1Y (TTM)64.58%
EPS 3Y20.01%
EPS 5Y7.07%
EPS Q2Q%52.17%
Revenue 1Y (TTM)13.57%
Revenue growth 3Y12.2%
Revenue growth 5Y15.83%
Sales Q2Q%4.58%

3.2 Future

Based on estimates for the next years, PETQ will show a very strong growth in Earnings Per Share. The EPS will grow by 20.07% on average per year.
The Revenue is expected to grow by 6.21% on average over the next years.
EPS Next Y34.03%
EPS Next 2Y25.33%
EPS Next 3Y23.23%
EPS Next 5Y20.07%
Revenue Next Year8.33%
Revenue Next 2Y6.86%
Revenue Next 3Y7.06%
Revenue Next 5Y6.21%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 19.61 indicates a rather expensive valuation of PETQ.
PETQ's Price/Earnings ratio is a bit cheaper when compared to the industry. PETQ is cheaper than 73.04% of the companies in the same industry.
PETQ's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.37.
A Price/Forward Earnings ratio of 16.30 indicates a correct valuation of PETQ.
PETQ's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PETQ is cheaper than 73.91% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.85, PETQ is valued a bit cheaper.
Industry RankSector Rank
PE 19.61
Fwd PE 16.3

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PETQ is valued a bit cheaper than the industry average as 73.04% of the companies are valued more expensively.
PETQ's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PETQ is cheaper than 60.87% of the companies in the same industry.
Industry RankSector Rank
P/FCF 77.88
EV/EBITDA 11.52

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of PETQ may justify a higher PE ratio.
PETQ's earnings are expected to grow with 23.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)2.77
EPS Next 2Y25.33%
EPS Next 3Y23.23%

0

5. Dividend

5.1 Amount

No dividends for PETQ!.
Industry RankSector Rank
Dividend Yield N/A

PETIQ INC

NASDAQ:PETQ (10/24/2024, 8:00:01 PM)

After market: 30.98 0 (0%)

30.98

-0.01 (-0.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07 2024-08-07/bmo
Earnings (Next)11-07 2024-11-07/amc
Inst Owners99.11%
Inst Owner Change5.73%
Ins Owners0.82%
Ins Owner Change-130.37%
Market Cap933.43M
Analysts76.36
Price Target31.11 (0.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.83%
Min EPS beat(2)33.29%
Max EPS beat(2)38.36%
EPS beat(4)4
Avg EPS beat(4)596.09%
Min EPS beat(4)33.29%
Max EPS beat(4)2252.94%
EPS beat(8)7
Avg EPS beat(8)329.26%
EPS beat(12)9
Avg EPS beat(12)214.99%
EPS beat(16)11
Avg EPS beat(16)161.03%
Revenue beat(2)1
Avg Revenue beat(2)-0.84%
Min Revenue beat(2)-2.32%
Max Revenue beat(2)0.63%
Revenue beat(4)3
Avg Revenue beat(4)7.73%
Min Revenue beat(4)-2.32%
Max Revenue beat(4)18.56%
Revenue beat(8)6
Avg Revenue beat(8)5.08%
Revenue beat(12)9
Avg Revenue beat(12)4.61%
Revenue beat(16)11
Avg Revenue beat(16)4.38%
PT rev (1m)0%
PT rev (3m)5.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.9%
EPS NY rev (1m)0%
EPS NY rev (3m)8.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 19.61
Fwd PE 16.3
P/S 0.82
P/FCF 77.88
P/OCF 46.16
P/B 3.62
P/tB N/A
EV/EBITDA 11.52
EPS(TTM)1.58
EY5.1%
EPS(NY)1.9
Fwd EY6.13%
FCF(TTM)0.4
FCFY1.28%
OCF(TTM)0.67
OCFY2.17%
SpS37.65
BVpS8.56
TBVpS-3.09
PEG (NY)0.58
PEG (5Y)2.77
Profitability
Industry RankSector Rank
ROA 1.48%
ROE 5.13%
ROCE 10.07%
ROIC 7.96%
ROICexc 9.02%
ROICexgc 20.48%
OM 6.32%
PM (TTM) 1.17%
GM 24.63%
FCFM 1.06%
ROA(3y)-2.53%
ROA(5y)-4%
ROE(3y)-9.44%
ROE(5y)-13.98%
ROIC(3y)4.51%
ROIC(5y)N/A
ROICexc(3y)5.32%
ROICexc(5y)N/A
ROICexgc(3y)14.77%
ROICexgc(5y)N/A
ROCE(3y)5.71%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y40.46%
ROICexc growth 3YN/A
ROICexc growth 5Y36.64%
OM growth 3YN/A
OM growth 5Y28.63%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.79%
GM growth 5Y7.79%
F-Score8
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 1.69
Debt/FCF 36.99
Debt/EBITDA 3.89
Cap/Depr 20.3%
Cap/Sales 0.73%
Interest Coverage 2.16
Cash Conversion 18.01%
Profit Quality 90.51%
Current Ratio 2.58
Quick Ratio 1.68
Altman-Z 2.6
F-Score8
WACC7.57%
ROIC/WACC1.05
Cap/Depr(3y)44.62%
Cap/Depr(5y)115.7%
Cap/Sales(3y)1.83%
Cap/Sales(5y)4.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.58%
EPS 3Y20.01%
EPS 5Y7.07%
EPS Q2Q%52.17%
EPS Next Y34.03%
EPS Next 2Y25.33%
EPS Next 3Y23.23%
EPS Next 5Y20.07%
Revenue 1Y (TTM)13.57%
Revenue growth 3Y12.2%
Revenue growth 5Y15.83%
Sales Q2Q%4.58%
Revenue Next Year8.33%
Revenue Next 2Y6.86%
Revenue Next 3Y7.06%
Revenue Next 5Y6.21%
EBIT growth 1Y62.93%
EBIT growth 3YN/A
EBIT growth 5Y48.99%
EBIT Next Year95.79%
EBIT Next 3Y33.01%
EBIT Next 5Y22.34%
FCF growth 1Y173.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y340.55%
OCF growth 3YN/A
OCF growth 5YN/A